IS8081A - Meðferð á ástandi þar sem amýlóíðskellur koma viðsögu - Google Patents

Meðferð á ástandi þar sem amýlóíðskellur koma viðsögu

Info

Publication number
IS8081A
IS8081A IS8081A IS8081A IS8081A IS 8081 A IS8081 A IS 8081A IS 8081 A IS8081 A IS 8081A IS 8081 A IS8081 A IS 8081A IS 8081 A IS8081 A IS 8081A
Authority
IS
Iceland
Prior art keywords
repaired
treatment
condition
amyloid plaques
amyloid
Prior art date
Application number
IS8081A
Other languages
English (en)
Icelandic (is)
Inventor
M. Strittmatter Stephen
H.S. Lee Daniel
Li Weiwei
Original Assignee
Yale University
Biogen Idec Ma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University, Biogen Idec Ma Inc filed Critical Yale University
Publication of IS8081A publication Critical patent/IS8081A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1787—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IS8081A 2003-04-16 2005-10-21 Meðferð á ástandi þar sem amýlóíðskellur koma viðsögu IS8081A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46342403P 2003-04-16 2003-04-16
PCT/US2004/011728 WO2004093893A2 (en) 2003-04-16 2004-04-16 Nogo-receptor antagonists for the treatment of conditions involving amyloid plaques

Publications (1)

Publication Number Publication Date
IS8081A true IS8081A (is) 2005-10-21

Family

ID=33310776

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8081A IS8081A (is) 2003-04-16 2005-10-21 Meðferð á ástandi þar sem amýlóíðskellur koma viðsögu

Country Status (15)

Country Link
US (1) US20070065429A1 (https=)
EP (1) EP1615654A2 (https=)
JP (1) JP2006523708A (https=)
KR (1) KR20060023959A (https=)
CN (1) CN1832752A (https=)
AU (1) AU2004231742A1 (https=)
BR (1) BRPI0409562A (https=)
CA (1) CA2522649A1 (https=)
EA (1) EA009643B1 (https=)
IS (1) IS8081A (https=)
MX (1) MXPA05011100A (https=)
NO (1) NO20055392L (https=)
RS (1) RS20050774A (https=)
WO (1) WO2004093893A2 (https=)
ZA (1) ZA200509242B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7119165B2 (en) * 2000-01-12 2006-10-10 Yale University Nogo receptor-mediated blockade of axonal growth
PT1534736E (pt) * 2002-08-10 2010-09-07 Univ Yale Antagonistas do receptor nogo
US20080274112A1 (en) * 2003-08-07 2008-11-06 Lee Daniel H S Nogo Receptor Antagonists
CA2549956C (en) * 2003-12-22 2016-04-12 Glaxo Group Limited Immunoglobulins
CA2555018A1 (en) * 2004-01-30 2005-08-18 Biogen Idec Ma Inc. Treatment of conditions involving dopaminergic neuronal degeneration using nogo receptor antagonists
US8269141B2 (en) 2004-07-13 2012-09-18 Lincoln Global, Inc. Power source for electric arc welding
US9956639B2 (en) 2005-02-07 2018-05-01 Lincoln Global, Inc Modular power source for electric ARC welding and output chopper
US9855620B2 (en) 2005-02-07 2018-01-02 Lincoln Global, Inc. Welding system and method of welding
US9647555B2 (en) 2005-04-08 2017-05-09 Lincoln Global, Inc. Chopper output stage for arc welder power source
CA2913655A1 (en) 2006-01-27 2007-08-09 Biogen Ma Inc. Nogo receptor antagonists
EP2081429A4 (en) * 2006-08-31 2010-01-06 Biogen Idec Inc PROCESS FOR PERIPHERAL ADMINISTRATION OF NOGO RECEPTOR POLYPEPTIDES
EP2276500A4 (en) 2008-03-13 2015-03-04 Univ Yale REACTIVATION OF AXON GROWTH AND AXON RECOVERY IN CHRONIC REVERSE MARKET INJURIES

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) * 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) * 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) * 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) * 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) * 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) * 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US5179017A (en) * 1980-02-25 1993-01-12 The Trustees Of Columbia University In The City Of New York Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4399216A (en) * 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4634665A (en) * 1980-02-25 1987-01-06 The Trustees Of Columbia University In The City Of New York Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4366241A (en) * 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4510245A (en) * 1982-11-18 1985-04-09 Chiron Corporation Adenovirus promoter system
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5168062A (en) * 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US4968615A (en) * 1985-12-18 1990-11-06 Ciba-Geigy Corporation Deoxyribonucleic acid segment from a virus
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
GB9014932D0 (en) * 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
WO1994004679A1 (en) * 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
JPH05244982A (ja) * 1991-12-06 1993-09-24 Sumitomo Chem Co Ltd 擬人化ｂ−ｂ１０
WO1999066041A1 (en) * 1998-06-16 1999-12-23 Human Genome Sciences, Inc. 94 human secreted proteins
US6391311B1 (en) * 1998-03-17 2002-05-21 Genentech, Inc. Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1
US20020072493A1 (en) * 1998-05-19 2002-06-13 Yeda Research And Development Co. Ltd. Activated T cells, nervous system-specific antigens and their uses
IL150566A0 (en) * 2000-01-12 2003-02-12 Univ Yale Nucleic acids and polypeptides and nogo-receptor proteins
US7119165B2 (en) * 2000-01-12 2006-10-10 Yale University Nogo receptor-mediated blockade of axonal growth
NZ525422A (en) * 2000-10-06 2006-09-29 Biogen Idec Inc Isolated polynucleotides comprising a nucleic acid which encodes a polypeptide which modulates axonal growth in CNS neurons
JP2005507246A (ja) * 2001-08-27 2005-03-17 ノバルティス アクチエンゲゼルシャフト Ｎｏｇｏレセプターホモログおよびそれらの使用
WO2003035687A1 (en) * 2001-10-22 2003-05-01 Novartis Ag Nogo receptor homologues and their use
PT1534736E (pt) * 2002-08-10 2010-09-07 Univ Yale Antagonistas do receptor nogo
US20080274112A1 (en) * 2003-08-07 2008-11-06 Lee Daniel H S Nogo Receptor Antagonists

Also Published As

Publication number Publication date
BRPI0409562A (pt) 2006-04-18
WO2004093893A2 (en) 2004-11-04
CA2522649A1 (en) 2004-11-04
KR20060023959A (ko) 2006-03-15
JP2006523708A (ja) 2006-10-19
AU2004231742A2 (en) 2004-11-04
EA200501620A1 (ru) 2006-06-30
RS20050774A (sr) 2007-12-31
NO20055392L (no) 2005-11-15
EA009643B1 (ru) 2008-02-28
US20070065429A1 (en) 2007-03-22
CN1832752A (zh) 2006-09-13
MXPA05011100A (es) 2006-04-18
ZA200509242B (en) 2006-12-27
AU2004231742A1 (en) 2004-11-04
EP1615654A2 (en) 2006-01-18
WO2004093893A3 (en) 2005-03-03

Similar Documents

Publication Publication Date Title
EP1903009A4 (en) APPARATUS AND METHOD FOR TREATING WATER FROM LESTAGE
ZA200705297B (en) Methods and compositions for treating amyloid related diseases
DE602006010822D1 (de) Schleifartikel und herstellungsverfahren dafür
NO20070251A (no) Brønnbehandling
NO20070297A (no) Brønnbehandling
LTC2213652I2 (lt) Stilbeno dariniai ir jų panaudojimas amiloido plokštelių surišimui ir vizualizacijai
IS7995A (is) Bensópýran efnasambönd sem nýtast við meðferð á ýmsum tegundum bólguástands
GB2426730B (en) Investment casting pins
EP1874143A4 (en) RIDING HOPPER AND METHOD OF MANUFACTURE
DE602005025091D1 (de) Piezooszillator und herstellungsverfahren dafür
EP1761105A4 (en) PRESSURE WAVE GENERATOR AND METHOD OF MANUFACTURING THE SAME
EP1998046A4 (en) Compressor, and its manufacturing method
IS8530A (is) Meðferð á truflunum í auga þar með talinni sjóndepilsrýrnun
IS8081A (is) Meðferð á ástandi þar sem amýlóíðskellur koma viðsögu
DE602006009540D1 (de) L und herstellungsverfahren dafür
IL187376A0 (en) Method of assessing the effectiveness of a treatment regimen
NO323496B1 (no) Fremgangsmate for rekondensering av avkoksgass
IS8520A (is) Sambrædd pýrrólókarbasól og aðferðir við framleiðslu þeirra
EP1873276A4 (en) SURFACE TREATMENT METHOD AND REPAIR PROCESS
DE602006020117D1 (de) Nadellager und herstellungsverfahren dafür
DE602006019395D1 (de) Media-behandlungseinrichtung
IS2372B (is) Tetrasólafleiður og aðferðir til að meðhöndla efnaskiptatengda sjúkdóma sem þeim tengjast
DE112006001414A5 (de) Gehäusekörper und Verfahren zu dessen Herstellung
NO20053296L (no) Anordning og fremgangsmate for rengjoring av kompressor
FR2873006B3 (fr) Lit gonflable